These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 8791884)

  • 1. Meropenem--an advantageous antibiotic?
    Drug Ther Bull; 1996 Jul; 34(7):53-5. PubMed ID: 8791884
    [No Abstract]   [Full Text] [Related]  

  • 2. Meropenem--a new parenteral broad-spectrum antibiotic.
    Med Lett Drugs Ther; 1996 Sep; 38(984):88-90. PubMed ID: 8828521
    [No Abstract]   [Full Text] [Related]  

  • 3. Population pharmacokinetics and pharmacodynamics of meropenem in pediatric patients.
    Du X; Li C; Kuti JL; Nightingale CH; Nicolau DP
    J Clin Pharmacol; 2006 Jan; 46(1):69-75. PubMed ID: 16397286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meropenem-aggravated seizure activity in progressive myoclonus epilepsy.
    Baraboutis IG; Marangos MN; Skoutelis A; Bassaris H
    Int J Antimicrob Agents; 2008 Feb; 31(2):177-9. PubMed ID: 18061410
    [No Abstract]   [Full Text] [Related]  

  • 5. Efficacy and tolerability of IV doripenem versus meropenem in adults with complicated intra-abdominal infection: a phase III, prospective, multicenter, randomized, double-blind, noninferiority study.
    Lucasti C; Jasovich A; Umeh O; Jiang J; Kaniga K; Friedland I
    Clin Ther; 2008 May; 30(5):868-83. PubMed ID: 18555934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elution and antibacterial activity of meropenem from implanted acrylic bone cement.
    Solomon AW; Stott PM; Duffy K; Kumar PG; Holliman RE; Bridle SH
    J Antimicrob Chemother; 2010 Aug; 65(8):1834-5. PubMed ID: 20519357
    [No Abstract]   [Full Text] [Related]  

  • 7. Bone marrow aplasia and meropenem in a paediatric patient.
    Estella J; Villanueva J; Calvo M; Toll MT; Alcorta I; Roca J; Jiménez R
    Br J Haematol; 2000 Dec; 111(3):984-5. PubMed ID: 11122164
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacokinetics and pharmacodynamics of meropenem in febrile neutropenic patients with bacteremia.
    Ariano RE; Nyhlén A; Donnelly JP; Sitar DS; Harding GK; Zelenitsky SA
    Ann Pharmacother; 2005 Jan; 39(1):32-8. PubMed ID: 15598967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of meropenem penetration into the lung from Sparse data.
    Kees MG; Lodise TP; Drusano GL
    Antimicrob Agents Chemother; 2011 Dec; 55(12):5959-61. PubMed ID: 22081725
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of concomitant administration of meropenem and valproic acid in an elderly Chinese patient.
    Gu J; Huang Y
    Am J Geriatr Pharmacother; 2009 Feb; 7(1):26-33. PubMed ID: 19281938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meropenem, a new carbapenem antibiotic.
    Fish DN; Singletary TJ
    Pharmacotherapy; 1997; 17(4):644-69. PubMed ID: 9250544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic and pharmacodynamic properties of meropenem.
    Nicolau DP
    Clin Infect Dis; 2008 Sep; 47 Suppl 1():S32-40. PubMed ID: 18713048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Update on the appropriate use of meropenem for the treatment of serious bacterial infections.
    Kollef MH
    Clin Infect Dis; 2008 Sep; 47 Suppl 1():S1-2. PubMed ID: 18713044
    [No Abstract]   [Full Text] [Related]  

  • 14. Meropenem: a new, extremely broad spectrum beta-lactam antibiotic for serious infections in pediatrics.
    Bradley JS
    Pediatr Infect Dis J; 1997 Mar; 16(3):263-8. PubMed ID: 9076812
    [No Abstract]   [Full Text] [Related]  

  • 15. Carbapenems: a potent class of antibiotics.
    Nicolau DP
    Expert Opin Pharmacother; 2008 Jan; 9(1):23-37. PubMed ID: 18076336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioequivalence, antibacterial activity and therapeutic outcome of a generic meropenem (Mapenem).
    Leelarasamee A; Rongrungruang Y; Trakulsomboon S; Pongpech P; Thanawattanawanich P; Jithavech P
    J Med Assoc Thai; 2008 Jul; 91(7):980-8. PubMed ID: 18839835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and effectiveness of meropenem in infants with suspected or complicated intra-abdominal infections.
    Cohen-Wolkowiez M; Poindexter B; Bidegain M; Weitkamp JH; Schelonka RL; Randolph DA; Ward RM; Wade K; Valencia G; Burchfield D; Arrieta A; Mehta V; Walsh M; Kantak A; Rasmussen M; Sullivan JE; Finer N; Rich W; Brozanski BS; van den Anker J; Blumer J; Laughon M; Watt KM; Kearns GL; Capparelli EV; Martz K; Berezny K; Benjamin DK; Smith PB;
    Clin Infect Dis; 2012 Dec; 55(11):1495-502. PubMed ID: 22955430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transient selective factor X deficiency in a severely burned child.
    Jennes S; Saidane G; Fauville JP; Ledoux M; Colinet B
    Burns; 2008 Nov; 34(7):1037-40. PubMed ID: 17919821
    [No Abstract]   [Full Text] [Related]  

  • 19. Considerations of meropenem dosage for bacterial meningitis based on pharmacodynamics in cerebrospinal fluid.
    Ikawa K; Morikawa N; Ikeda K; Tsumura R; Shibukawa M; Iida K; Kurisu K
    Int J Antimicrob Agents; 2008 Jul; 32(1):96-8. PubMed ID: 18539005
    [No Abstract]   [Full Text] [Related]  

  • 20. [Meropenem and valproic acid: a dangerous combination].
    Eimil-Ortiz M; Aguirre-Mollehuanca D; Sierra-Limpo A; Fontán-Tirado C; Villar-Villar ME
    Rev Neurol; 2008 Jan 16-31; 46(2):124-5. PubMed ID: 18247286
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.